The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatology Can Use MACRA to Drive Healthcare Improvements

Rheumatology Can Use MACRA to Drive Healthcare Improvements

May 18, 2018 • By Terence W. Starz, MD, Theodore Pincus, MD, & Janet Bahr, NP, on behalf of the ARHP Practice Committee

  • Tweet
  • Email
Print-Friendly Version / Save PDF

We have entered the second year of the Medicare Access and CHIP (Children’s Health Insurance Program) Reauthorization Act (MACRA) of 2015. It’s no secret that the costs of medical care—17.1% of the U.S. gross national product compared with 9.8% in Great Britain, 10.7% in Canada and 11.6% in France—have become an overwhelming driver for change. Further, outcomes in the U.S. appear no better and frequently poorer in many categories than in most advanced societies. The U.S. healthcare system must become more efficient and cost effective.

You Might Also Like
  • Prepare Now—Not Later—to Meet New Medicare Reimbursement Requirements
  • MACRA: More Points, Smarter Future
  • MACRA: Tips & Tools for Rheumatology Staff
Explore This Issue
May 2018

Physicians and other health professionals have expressed frustration, anger and despair about MACRA, feeling that we have no input or control. Certainly, this is no time to be a Pollyanna. However, MACRA could function as a springboard for changes that address fundamental financial and care activity problems that we experience in rheumatology. We need to focus on what we aspire to do best: Provide the highest quality care to our patients in the most efficient, cost-effective way possible. MACRA is the current requirement, which we can try to use as a tool to improve patient outcomes.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

What It Is

MACRA quite simply is the legislation that defines the formula by which 400,000 healthcare professionals are paid for services provided to Medicare beneficiaries. It replaces Congress’ 1997 Balanced Budget Act, which determined the budget for Medicare Part B to ensure that yearly increases did not exceed the growth in gross domestic product. Implementation of that Act included a yearly Sustainable Growth Rate (SGR) adjustment to provide for formula variations, the so-called doc fix, in order to maintain adequate reimbursement to providers. However, by 2014, the SGR adjustment would have resulted in a 24% cut in Medicare reimbursement for physicians, which might have led many physicians to leave the program and was not actually sustainable. Hence, MACRA was passed with strong bipartisan support.

MACRA is not part of the Affordable Care Act; although there may be changes, it is the current policy of the Centers for Medicare and Medicaid Services (CMS) for reimbursement. We must do our best to adapt.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

MACRA mandates a dramatic departure from SGR to a system that is value-driven by quality and is determined by patient care measures. The MACRA model, called the Quality Payment Program, assigns each participating healthcare professional a numerical score based on a formula of measures provided by the CMS, which include healthcare expenditures (costs) that are directly attributed to that professional’s services.

Pages: 1 2 3 4 | Single Page

Filed Under: Legislation & Advocacy, Professional Topics Tagged With: Alternative Payment Model, APM, MACRA, Medicare Access and CHIP Reauthorization Act, Merit-Based Incentive Payment, MIPSIssue: May 2018

You Might Also Like:
  • Prepare Now—Not Later—to Meet New Medicare Reimbursement Requirements
  • MACRA: More Points, Smarter Future
  • MACRA: Tips & Tools for Rheumatology Staff
  • Brave New MACRA World

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.